1. Deftos, LJ: Clinical Essentials of Calcium and Skeletal Metabolism, Professional Communication Inc, First Edition, pp. 1-208, 1998 (Published on-line at Medscape.com).

2. Brown EM: Physiology of Calcium Homeostasis. In: The Parathyroids, Second Editon, JP Bilezikian, R Marcus, and A Levine (eds.); Chapter 10, pp. 167-182, 2001.

3. Bruder JM, Guise TA, and Mundy GR: Mineral Metabolism. In: Endocrinology & Metabolism, Fourth Edition, P. Felig and LA Frohman (eds.); Chapter 22, pp.10791159, 2001.

4. Drezner, MK: Phosphorus Homeostasis and Related Disorders. In: Principles of Bone Biology, Second Edition, JP Bilezikian, LG Raisz, and GA Rodan (eds.); Chapter 22, pp.321-338, 2002.

5. Yanagawa N and Lee DBN: Renal Handling of Calcium and Phosphorus. In: Disorders of Bone and Mineral Metabolism, FL Coe and MJ Favus (eds.); Chapter 1, pp.3-40, 1992.

6. Favus MJ: Intestinal Absorption of Calcium, Magnesium, and Phosphorus. In: Disorder of Bone and Mineral Metabolism, FL Coe and MJ Favus (eds.); Chapter 3, pp. 57-82, 1992.

7. Reuss, L: Basic Mechanisms of Ion Transport. In: The Kidney, Third Edition, DW Seldin and G Giebisch (eds.); Chapter 3, pp.85-106, 2000.

8. Berger UV, Peng JB, and Hedier MA: The membrane transporter families in mammals. In: The Kidney, Third Edition, DW Seldin and G Giebisch (eds.); Chapter 4, pp. 107-138, 2000.

9. Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165?176, 1998.

10. Deftos, LJ: Hypercalcemia in malignant and inflammatory diseases. Endocrinology and Metabolism Clinics of North America 31:1-18, 2002.

11. Brown EM, Hebert SC. Calcium?receptor?regulated parathyroid and renal function. Bone 20:303?309, 1997.

12. Deftos, LJ: Immunoassays for PTH and PTHrP In: The Parathyroids, Second Edition, JP Bilezikian, R Marcus, and A Levine (eds.), Chapter 9, pp.143-165, 2001.

13. Brown EM, Segre GV, and Goldring SR: Serpentine receptors for parathyroid hormone, calcitonin and extracellular calcium ions. Baillieres Clin Endocrinol Metab 10:123-161, 1996.

14. Knecht TP, Behling CA, Burton DW, Glass CK, Deftos LJ. The humoral hypercalcemia of benignancy. A newly appreciated syndrome. Am J Clin Pathol 105:487?492, 1996.

15. Deftos LJ and Gagel R: Calcitonin and Medullary Thyroid Carcinoma In: Cecil Textbook of Medicine, Twentieth First Edition, JB Wyngarden and JC Bennett, Chapter 265, pp.1406-1409, 2000.

16. Deftos LJ, Weisman MH, Williams GW, et al. Influence of age and sex on plasma calcitonin in human beings. N Engl J Med 302:1351?1353, 1980.

17. Deftos LJ. There's something fishy and perhaps fowl about the mammalian calcitonin receptor and its ligand. Endocrinology 138:519?520, 1997. Editorial.

18. McLatchie LM, Fraser NJ, Main MJ, et al. RAMPs regulate the transport and ligand specificity of the calcitonin?receptor?like receptor. Nature 393:333?339, 1998.

19. Muff R, Born W, Fischer JA. Calcitonin, calcitonin gene?related peptide, adrenomedullin and amylin: homologous peptides, separate receptors and overlapping biological actions. Eur J Endocrinol 133:17?20, 1995.

20. Haussler MR, Whitfield GK, Haussler CA, et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 13:325?349, 1998.

21. Holick, MF: Photobiology and Noncalcemic Actions of Vitamin D. In: Principles of Bone Biology, Second Edition, JP Bilezikian, LG Raisz, and GA Rodan (eds.); Chapter 33, pp.587-602, 2002.

22. Bell NH. Renal and nonrenal 25?hydroxyvitamin D?1a?hydroxylases and their clinical significance. J Bone Miner Res 13:350?353, 1998.

23. Nemere I, Farach?Carson MC. Membrane receptors for steroid hormones: a case for specific cell surface binding sites for vitamin D metabolites and estrogens. Biochem Biophys Res Commun 248:443?449, 1998.